Georgia's Online Cancer Information Center

Find A Doctor

Harry F. Moore, Jr. MD
Harry F. Moore, Jr. MD
Central Georgia Cancer Care, PC - Macon
www.centralgeorgiacancercare.com

Harry F. Moore, Jr. MD

Specialty
Internal Medicine / Board Certified
Trial Cancers
Breast Cancer, Eye Cancer, Lung Cancer, Lymphoma, Multiple Primaries, Non-Hodgkin Lymphoma, Solid Tumor
Affiliations
American Society of Clinical Oncology
American Society of Hematology
American Cancer Society

Active Clinical Trial Sites in Georgia

Central Georgia Cancer Care

114 Sutherlin Dr.
Suite C-1
Warner Robins, GA 31088
478-287-6353 (p)
www.centralGeorgiaradiation.com/

driving directions





The Medical Center of Central Georgia

Oncology Research, Navicent Health
777 Hemlock Street, MSC 123
(800 1st Street, Suite 250)
Macon, GA 31201
478-633-3000 (p)
478-633-8894 (f)
www.navicenthealth.org

driving directions

Clinical Trials
A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy vs. Observation in Patients with Residual Triple-Negative Basal-like Breast Cancer following Neoadjuvant Chemotherapy
Cancer Type: Breast Cancer

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Cancer Type: Breast Cancer

A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial
Cancer Type: Breast Cancer

EAY131: Molecular Analysis for Therapy Choice (NCI-MATCH)
Cancer Type: Eye Cancer

Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
Cancer Type: Lung Cancer

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Cancer Type: Lung Cancer

A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Placebo for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Cancer Type: Lung Cancer

EAY131: Molecular Analysis for Therapy Choice (NCI-MATCH)
Cancer Type: Lymphoma

EAY131: Molecular Analysis for Therapy Choice (NCI-MATCH)
Cancer Type: Multiple Primaries

EAY131: Molecular Analysis for Therapy Choice (NCI-MATCH)
Cancer Type: Non-Hodgkin Lymphoma

EAY131: Molecular Analysis for Therapy Choice (NCI-MATCH)
Cancer Type: Solid Tumor

EAY131: Molecular Analysis for Therapy Choice (NCI-MATCH)
Cancer Type: Unknown Primary
**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please contact us.
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.